XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Jun. 29, 2024
Jul. 01, 2023
Cash flows from operating activities:    
Net income $ 34,900,000 $ 37,000,000.0
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 48,200,000 51,300,000
Stock-based compensation expense 23,100,000 (1,300,000)
Provision for credit losses 400,000 500,000
Amortization of debt issuance cost 900,000 900,000
Changes in operating assets and liabilities:    
Decrease (increase) in accounts receivable 13,100,000 95,900,000
Decrease (increase) in inventories 7,600,000 (45,500,000)
Decrease (increase) in other current assets 3,400,000 (8,800,000)
Decrease (increase) in lease receivable, net 4,900,000 (4,400,000)
Decrease (increase) in deferred costs and other contract assets (1,600,000) (400,000)
Decrease (increase) in other non-current assets (1,400,000) (24,400,000)
Increase (decrease) in accounts payable (22,500,000) (11,800,000)
Increase (decrease) in accrued compensation 10,300,000 (39,000,000.0)
Increase (decrease) in accrued liabilities 17,100,000 (19,700,000)
Increase (decrease) in income tax payable (1,300,000) 5,000,000.0
Increase (decrease) in deferred revenue and other contract-related liabilities (7,100,000) (6,800,000)
Increase (decrease) in other non-current liabilities (9,700,000) (4,500,000)
Net cash provided by (used in) operating activities 120,300,000 24,000,000.0
Cash flows from investing activities:    
Purchases of property and equipment (15,800,000) (20,400,000)
Proceeds from sale of property and equipment 10,800,000 0
Increase in intangible assets (16,100,000) (19,900,000)
Business combinations, net of cash acquired 0 7,500,000
Other strategic investing activities (100,000) (700,000)
Net cash (used in) provided by investing activities (21,200,000) (33,500,000)
Cash flows from financing activities:    
Borrowings under line of credit 64,000,000.0 79,000,000.0
Repayments on line of credit (185,600,000) (112,400,000)
Proceeds from issuance of common stock 9,900,000 6,000,000.0
Payroll tax withholdings on behalf of employees for vested equity awards (5,800,000) (12,700,000)
Net cash (used in) provided by financing activities (117,500,000) (40,100,000)
Effect of foreign currency exchange rates on cash (14,200,000) (1,400,000)
Net decrease in cash, cash equivalents and restricted cash (32,600,000) (51,000,000.0)
Cash, cash equivalents and restricted cash at beginning of period 168,200,000 209,600,000
Cash, cash equivalents and restricted cash at end of period $ 135,600,000 $ 158,600,000